A mouse model of Mpl hyperactivity in vivo, however, is sufficient to produce bone marrow fibrosis that resembles that observed in MF: Tpo treatment of mice induces bone marrow fibrosis, and this has been used as a model to study this pathophysiologic process, albeit in the absence of a malignant clone (74). The gene discussed is MPL; the disease is primary myelofibrosis.